ALL ABOUT LIPS
ALL ABOUT LIPS
Visual AI generated
With concerns around overfilled lips, migration, and asymmetry increasingly shaping the perception of lip filler, JUVÉDERM® set out to rebuild trust in the gel technology that powers their lip SKUs.
This page focuses on brochure messaging. Some visuals are AI-generated for illustrative purposes and are clearly labeled, distinct from original brand imagery.
HCP Brochure Concept
As part of their lip SKU revitalization, we created a brochure for JUVÉDERM® Ultra & Ultra Plus to help HCPs connect with and educate patients:
Original brochure cover
The brochure opens right at the lips, so the first interaction is built into the cover. It gives patients something to engage with while offering HCPs an easy way to begin the consultation conversation.
Introduction
For the opening copy, I focused on lips as part of self-expression and set up the role of the HCP in shaping results:
Above visual AI generated
WHY LIPS MATTER?
To us, lips are more than aesthetics: They’re central to how you communicate and express yourself. At Allergan Aesthetics™, we understand that your idea of what makes lips beautiful is truly unique.
Many people seek subtle enhancements as part of their aesthetic journey. With JUVÉDERM® treatments, your health care professional has the potential to help you achieve your cosmetic goals.
Messaging Approach
With JUVÉDERM® being part of Allergan Aesthetics’ portfolio of evidence-based injectables, I made the clinical and patient-reported data the highlight:
JUVÉDERM® Ultra Messaging
Model has been treated with JUVÉDERM®. Individual results may vary. Visual has been extended with AI to create vertical layout.
THE SCIENCE BEHIND JUVÉDERM® GELTECHNOLOGY
JUVÉDERM® offers smooth, cohesive gels (6,7) that begin to integrate with your tissue as early as 1 week (*3), by helping deliver smooth lips that feel natural (8):
81%
FELT THEIR LIPS LOOKED AND FELT ‘SMOOTH’ (**2)
JUVÉDERM® ULTRA gel properties are well suited for lips, helping you achieve fullness and definition that suits your style. (1,3,4)
JUVÉDERM® FOR LIPS
JUVÉDERM® can enhance your lips (***3), whilst still looking natural, creating an aesthetic tailored to you.
JUVÉDERM® can help you achieve long-lasting results when it comes to both: lip fullness & definition. (†2)
JUVÉDERM® Ultra Plus Messaging
Model has been treated with JUVÉDERM®. Individual results may vary. Visual has been extended with AI to create vertical layout.
THE SCIENCE BEHIND JUVÉDERM® HA GEL TECHNOLOGY
JUVÉDERM® offers smooth, cohesive gels that integrate with your tissue as early as 1 week, by helping deliver smooth lips that feel natural (8):
98%
FEEL THEIR LIPS LOOKED NATURAL AFTER TREATMENT WITH JUVÉDERM® ULTRA PLUS (**2)
JUVÉDERM® ULTRA Plus increased lip fullness, with the net lip volume score of patients doubling from 1.2 to 2.4 after treatment. (**2) ALL PATIENTS reported improved lip appearance and smoothness. (**2)
JUVÉDERM® FOR LIPS
JUVÉDERM® can enhance your lips (***3), whilst still looking natural, creating an aesthetic tailored to you.
JUVÉDERM® can help you achieve long-lasting results when it comes to both: lip fullness & definition. (†2)
Gel Technology
We created a diagram-led flow that visualized how JUVÉDERM® Ultra & Ultra Plus integrate into the lips:
YOUR JUVÉDERM® TREATMENT
Whether you’re looking for subtle refinement or enhanced volume: with JUVÉDERM®, your healthcare professional can inject precisely thanks to the varying degrees of gel firmness, helping you bring to life your vision. (10)
IF YOU ARE CONSIDERING LIP TREATMENTS, ASK YOUR HEALTHCARE PROFESSIONAL WHETHER JUVÉDERM® MAY BE SUITABLE FOR YOU.
Footnotes
JUVÉDERM ULTRA
*Tissue integration was demonstrated by Juvéderm® ULTRA XC, Juvéderm® ULTRA PLUS XC, JUVÉDERM® VOLITE, Juvéderm® VOLBELLA with lidocaine, Juvéderm® VOLIFT with lidocaine, Juvéderm® VOLUMA with lidocaine and Juvéderm® VOLUX at 1 and 4 weeks in animal in vivo studies.9 **Data collected from an ongoing, multicenter, single-blind study using Juvéderm® ULTRA XC that randomized 213 subjects to the treatment group (N = 157) or concurrent no-treatment control group that received delayed treatment (N = 56).2 ***Data from clinical study where patients were treated in the lips with Juvéderm® Ultra 3 (ULTRA SMILE). 98 % of patients (N=57) felt their lips looked natural post-treatment.3 †56.4% of subjects (N=157) treated with JUVÉDERM® ULTRA XC maintained treatment response for 12 months.2
JUVÉDERM ULTRA PLUS
*Tissue integration was demonstrated by Juvéderm® ULTRA XC, Juvéderm® ULTRA PLUS XC, Juvéderm® VOLITE, Juvéderm® VOLBELLA with lidocaine, Juvéderm® VOLIFT with lidocaine, Juvéderm® VOLUMA with lidocaine and JUVÉDERM® VOLUX at 1 and 4 weeks in animal in vivo studies.7 **Data from clinical study where patients were treated in the lips with Juvéderm® ULTRA 3 (ULTRA SMILE). 98 % of patients (N=57) felt their lips looked natural post-treatment.2 ***56.4 % of subjects (N = 157) maintained treatment response for 12 months.
References
1. Juvéderm® ULTRA 2 DFU. 73661JR10. Revision, 2019-09-09. 2. Dayan S, et al. Dermatol Surg. 2015;41(Suppl. 1):S293–S301. 3. Lanigan S. J Cosmet Dermatol. 2011; 10:11–14. 4. Juvéderm® ULTRA SMILE DFU. 73664JR10. Revision 2019-09-09. 5. Juvéderm® ULTRA PLUS XC DFU. 73660RX10. Revision, 2019-09-09. 6. Goodman GJ et al. Plast Reconstr Surg. 2015;136:S139–48. 7. Levy PM, et al. Dermatol Surg. 2009;35 Suppl 1:332-337. 8. Hee CK et al. Dermatol Surg. 2015; 41(Suppl 1):S373–81. 9. Allergan Aesthetics. Data on File. REF-140058. ABVRRTI81526 Juvéderm Vycross and Hylacross - Tissue Integration Images. August 2025. 10. Smith KC. Plast Reconstr Surg. 2007; 120(6 Suppl):67S-73S. 11. Allergan Aesthetics - Science - Pipeline Available at: https://www.abbvie.com/science/pipeline.html Accessed August 2024.
Material provided by Allergan Aesthetics, an AbbVie company, under a licensing agreement. This content is intended for [insert country name] adult (>18yrs) audience only. You should always consult a healthcare professional to help you decide if Allergan Aesthetics facial treatments are right for you and provide you with a full list of side effects. Adverse events should be reported to Allergan Aesthetics, an AbbVie company [insert local contact details for AE reporting].
Patients may experience potential side effects after treatment with JUVÉDERM® fillers, which may occur immediately or may be delayed. These include: inflammatory reactions (redness, oedema, erythema, etc.), haematomas, induration or nodules, staining or discolouration (e.g. Tyndall effect) at the injection site, poor or weak filling effect etc. Please refer to the specific JUVÉDERM® filler Direction For Use (DFU) for a full list of potential side effects. Reference relevant DFUs.